Paving the Way for Biomedical Innovation

The Frederick National Laboratory is meeting the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

'Empanada' is a leap forward in rapid 3-D image processing and annotation

It sounds like a pastry but it’s really part of a new wave in scientific imaging. Empanada is the name of an artificial...

Newly identified antibodies block many influenza strains in laboratory tests

Seeking a universal flu vaccine, scientists have identified two antibodies that block a wide range of influenza viruses by...

Microscopy mini-course teaches critical but often missing skills

Ru-ching Hsia, Ph.D., heard the same concern from colleagues across the country: There is a dearth of electron microscopy...

Biotech Connector explores the high-resolution world of electron microscopy

The spring Biotech Connector, a quarterly networking and speaker series, on May 23 gave an overview of the electron...

Scientists say effective control of COVID-19 depends on universal use of serological standards

Despite the growing volume of data from results of hundreds of COVID-19 serology test kits, experts say the differences among...

Comparative analysis adds evidence in favor of one-dose HPV vaccination in girls

An analysis of data from two clinical trials in sub-Saharan Africa, a region with one of the highest cervical cancer rates...

Conference: FNL joins two panels at 2024 BIO International Convention

Partnership development leaders at the Frederick National Laboratory for Cancer Research (FNL) will share their perspectives...
What is this?

Representative picture of colon of infected RM- that was infused with engineered CD8+ T cells to reduce the viral load. The Tissue Analysis and Retroviral Protein Core provides state-of-the-art tissue analysis capabilities.


Scientific Standards Hub

Our scientists establish standards and reference reagents for diverse scientific  disciplines and  encourage the adoption of benchmarks  among researchers. 
disciplines with tools to help bridge gaps in scientific reproducibility.

RAS Initiative

The RAS Initiative mobilizes the cancer research community to develop ways to treat cancers driven by the mutant RAS gene in an open model of collaboration among government, academic, and industry researchers.
People per year in the U.S. are diagnosed with cancers caused by KRAS mutations.
What is this? Surface representation of the structure of an oncogenic mutant of KRAS in complex with RAS-binding domains of RAF1 Kinase. The GMPPNP bound to oncogenic KRAS mutant is shown in ball-and-stick representation.

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.